Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ITP-NODAT early insulin prevention study in kidney transplant recipients
2012-000225-51Phase 2Completed
- Sponsor
- Hospital del Mar Research Institute
- Start
- Aug 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of insulin isophane in diabetes mellitus (DM) and carbohydrate malabsorption (2 arms), sponsored by Hospital del Mar Research Institute. Primary endpoint: Incidence of new-onset diabetes after transplantation at 12 months. Started Aug 2012; status: completed.
02
Drugs
insulin isophane
03
Conditions
diabetes mellitus (DM)carbohydrate malabsorption
Beyond the preview
Go deeper on 2012-000225-51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000225-51.